Pathogenetic implications of DNA nondiploidy in colorectal cancers

Diseases of the Colon and Rectum

Volumn 40, Issue 10, 1997, Pages 1244-1247

  Changchien, Chung Rong ^a   Wang, Jeng Yi ^a   Tang, Reiping ^a   Ho, Yat Sen ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Colorectal cancer; DNA ploidy; Pathogenesis

Indexed keywords

ARTICLE; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PLOIDY;

COLORECTAL NEOPLASMS; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; PLOIDIES; RETROSPECTIVE STUDIES;

EID: 0030861965     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02055172     Document Type: Article

References (23)

1. Beart RW, Melton LJ III, Maruta M, Dockerty MB, Frydenberg HB, O'Fallon WM. Trends in right and left-sided colon cancer. Dis Colon Rectum 1983;26:393-8.
2. Rhodes JB, Holmes FF, Clark GM. Changing distribution of primary cancers in the large bowel. JAMA 1977;238:1641-3.
3. Delattre O, Law DJ, Remvikos Y, et al. Multiple genetic alterations in distal and proximal colorectal cancer. Lancet 1989;2:353-5.
4. Watatani M, Yoshida T, Kuroda K, Ieda S, Yasutomi M. Allelic loss of chromosome 17p, mutation of the p53 gene, and microsatellite instability in right- and left sided colorectal cancer. Cancer 1996;77:1688-93.
5. Rothberg PG, Spandorfer JM, Erisman MD, et al. Evidence that c-myc expression defines two genetically distinct forms of colorectal adenocarcinoma. Br J Cancer 1985;52:629-32.
6. Mulder JW, Kruyt PM, Sewnath M, et al. Difference in expression of CD44 splice variants between proximal and distal adenocarcinoma of the large bowel. BrJ Surg 1995;82:1468-70.
7. Offerhaus GJ, De Feyter EP, Cornelisse CJ, et al The relationship of DNA aneuploidy to molecular genetic alterations in colorectal carcinoma. Gastroenterology 1992;102:1612-9.
8. Remvikos Y, Laurent-Puig P, Salmon RJ, Frelat G, Dutrillaux B, Thomas G. Simultaneous monitoring of p53 protein and DNA content of colorectal adenocarcinomas by flow cytometry. Int J Cancer 1990;45:450-6.
9. Meling GI, Lothe RA, Borresen AL, et al. The TP53 tumour suppressor gene in colorectal carcinomas. II. Relation to DNA ploidy pattern and clinicopathological variables. Br J Cancer 1993;67:93-8.
10. Tang R, Ho YS, You YT, et al. Prognostic evaluation of DNA flow cytometric and histopathologic parameters of colorectal cancer. Cancer 1995;76:1724-30.
11. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 1983;31:1333-5.
12. Greene FL. Distribution of colorectal neoplasms - a left to right shift of polyps and cancer. Am Surg 1983;49:62-5.
13. Reichmann A, Martin P, Levin B. Marker chromosomes in direct preparation of human large bowel tumors. Cancer Genet Cytogenet 1985;16:229-33.
14. Levin B, Reichmann A. Chromosomes and large bowel tumors. Cancer Genet Cytogenet 1986;19:159-62.
15. Bos JL, Fearon ER, Hamilton SR, et al. Prevalence of ras gene mutations in colorectal cancers. Nature 1987;327:293-70.
16. Kern SE, Fearon ER, Kasper WF, et al. Clinical and pathological associations with allelic loss in colorcast carcinoma. JAMA 1989;261:3099-103.
17. Carder PJ, Cripps KJ, Morris R, et al. Mutation of the p53 gene precedes aneuploid clonal divergence in colorectal carcinoma. Br J Cancer 1995;71:215-8.
18. Chapman MA, Hardcastle JD, Armitage NC. Five-year prospective study of DNA tumor ploidy and colorectal cancer survival. Cancer 1995;76:383-7.
19. Rognum TO, Thorud E, Lund E. Survival of large bowel carcinoma patients with different DNA ploidy. Br J Cancer 1987;56:633-6.
20. Scott NA, Weiand HS, Moertel CG, Cha SS, Beart RW, Lieber MM. Colorectal cancer: Dukes' stage, tumor site, preoperative plasma CEA level and patient prognosis related to DNA ploidy pattern. Arch Surg 1987;122:1375-9.
21. Kokal W, Sheibani K, Terz J, Harada JR. Tumor DNA content in the prognosis of colorectal carcinoma. JAMA 1986;2555:3123-7.
22. Lazaris AC, Davaris P, Nakopoulou L, Theodoropoulos GE, Koullias G, Golematis BC. Correlation between immunohistochemical expression of proliferating cell nuclear antigen and flow cytometry parameters in colorectal neoplasia. Dis Colon Rectum 1994;37:1083-9.
23. Finan PJ, Quirke P, Dixon MF, DysonJE, Giles GR, Bird CC. Is DNA aneuploidy a good prognostic indicator in patients with advanced colorectal cancer? Br J Cancer 1986;54:327-30.